Key result
Pretreatment with verapamil, ryanodine, and the protein kinase A inhibitor H-8 significantly suppressed dofetilide-induced torsades de pointes in a rabbit model of heart failure.
Why the study?
Does blockade of L-type Ca2+ channels, ryanodine receptors, or protein kinases prevent dofetilide-induced TdP in a rabbit model of heart failure?
Does blockade of L-type Ca2+ channels, ryanodine receptors, or protein kinases prevent dofetilide-induced TdP in a rabbit model of heart failure?
Absolute Event Rate: 0% vs 100%
p-value: p=<0.01
Blockade of L-type Ca2+ channels, ryanodine receptors, and protein kinase A prevents dofetilide-induced TdP in failing rabbit hearts, highlighting the role of intracellular Ca2+ overload and signaling in drug-induced arrhythmias.
QT prolongation may increase the risk of torsades de pointes (TdP). Early afterdepolarizations (EADs) and transmural dispersion of repolarization have been known to serve as physiological substrates and predictors for TdP. Abnormal Ca(2+) cycling is the proximate cause of EADs, and Ca(2+) cycling is abnormal in heart failure (HF). However, the mechanisms for drug-induced TdP in HF are poorly understood. The purpose of this study was to search for torsadogenic-modifying effects of verapamil, ryanodine, KB-R7943, W-7, KN-93, and H-8 on ventricular premature depolarizations (VPD) and TdP in rabbits with HF. Rabbits with HF were pretreated with propranolol followed by test articles before continuous infusion of dofetilide to induce TdP. In the control hearts, VPD and TdP were induced in all rabbits and the onsets of VPD and TdP were 3.6 +/- 1.3 minutes and 10.3 +/- 1.4 minutes, respectively. Dofetilide lengthened RR, QT and QTc. Verapamil, ryanodine and H-8 significantly delayed onset of VPD (P < 0.05) and suppressed TdP (P < 0.01). KB-R7943, W-7, and KN-93 accelerated onset of TdP. Blockades of L-type Ca(2+) channel, ryanodine channel, and protein kinase A prevent dofetilide-induced TdP, suggesting roles for intracellular Ca(2+) overload and Ca(2+) signaling pathways in drug-induced TdP.
No takes yet. Share an insight, caveat, or question.
Kijtawornrat et al. (2010) studied Heart Failure (n=39). Verapamil, ryanodine, and H-8 vs. Vehicle was evaluated on Incidence of dofetilide-induced Torsades de Pointes (TdP) (p=<0.01). Pretreatment with verapamil, ryanodine, and the protein kinase A inhibitor H-8 significantly suppressed dofetilide-induced torsades de pointes in a rabbit model of heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: